Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors

about

Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells.

P2860

Q37644981-43C47DD3-8AE3-4D7D-9D2A-32C1AF3CDE64

P2860

Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors

Item

http://www.wikidata.org/entity/Q38761522

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Progestin-mediated activation ...... embrane progesterone receptors

@en

type

Item

label

Progestin-mediated activation ...... embrane progesterone receptors

@en

prefLabel

Progestin-mediated activation ...... embrane progesterone receptors

@en

P1476

Progestin-mediated activation ...... embrane progesterone receptors

@en

P2093

Alejandra Lerma-Ortiz

http://www.w3.org/2001/XMLSchema#string

Amanda K Ashley

http://www.w3.org/2001/XMLSchema#string

Grace M Hooks

http://www.w3.org/2001/XMLSchema#string

Monica Salazar

http://www.w3.org/2001/XMLSchema#string

Ryan L Ashley

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes

Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor.

Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors δ and {epsilon} (mPRδ and mPR{epsilon}) and mPRδ involvement in neurosteroid inhibition of apoptosis

Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PG

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

All progestins are not created equal

Classification and pharmacology of progestins

Progesterone inhibits growth and induces apoptosis in breast cancer cells: inverse effects on Bcl-2 and p53

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Progesterone receptor membrane component 1: an integrative review.

P304

6-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.GENE.2016.06.044

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

591

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27349565

http://www.w3.org/2001/XMLSchema#string

P932

4992424

http://www.w3.org/2001/XMLSchema#string

Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors

about

P2860

P2860

Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932